Exponent Inc. (NASDAQ:EXPO)’s share price reached a new 52-week high on Tuesday . The company traded as high as $59.36 and last traded at $59.36, with a volume of 42,903 shares changing hands. The stock had previously closed at $58.96.

A number of research firms recently weighed in on EXPO. Zacks Investment Research upgraded shares of Exponent from a “hold” rating to a “buy” rating and set a $57.00 price objective on the stock in a research report on Friday, April 22nd. Avondale Partners began coverage on shares of Exponent in a research report on Thursday, July 7th. They issued a “market perform” rating and a $60.00 price objective on the stock.

The company has a market cap of $1.54 billion and a P/E ratio of 33.34. The company has a 50 day moving average of $55.45 and a 200 day moving average of $50.56.

Exponent (NASDAQ:EXPO) last released its earnings results on Wednesday, April 20th. The company reported $0.40 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.35 by $0.05. During the same quarter last year, the company posted $0.75 earnings per share. The business had revenue of $79 million for the quarter, compared to analysts’ expectations of $77.15 million. The business’s quarterly revenue was up 3.8% compared to the same quarter last year. Equities research analysts predict that Exponent Inc. will post $1.84 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Friday, June 24th. Stockholders of record on Friday, June 10th were paid a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 1.22%. The ex-dividend date of this dividend was Wednesday, June 8th.

In other news, Director Stephen C. Riggins sold 3,200 shares of the stock in a transaction that occurred on Monday, April 25th. The stock was sold at an average price of $49.32, for a total transaction of $157,824.00. Following the completion of the transaction, the director now directly owns 2,650 shares in the company, valued at approximately $130,698. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Paul R. Johnston sold 5,578 shares of the stock in a transaction that occurred on Friday, July 8th. The shares were sold at an average price of $58.15, for a total value of $324,360.70. Following the transaction, the chief executive officer now owns 64,458 shares of the company’s stock, valued at $3,748,232.70. The disclosure for this sale can be found here.

Several institutional investors have added to or reduced their stakes in EXPO. Comerica Bank boosted its position in Exponent by 0.7% in the fourth quarter. Comerica Bank now owns 27,900 shares of the company’s stock valued at $1,322,000 after buying an additional 203 shares during the period. California State Teachers Retirement System boosted its position in Exponent by 1.6% in the fourth quarter. California State Teachers Retirement System now owns 48,123 shares of the company’s stock valued at $2,404,000 after buying an additional 770 shares during the period. Rhumbline Advisers boosted its position in Exponent by 6.3% in the fourth quarter. Rhumbline Advisers now owns 33,165 shares of the company’s stock valued at $1,657,000 after buying an additional 1,980 shares during the period. California Public Employees Retirement System raised its stake in Exponent by 11.6% in the fourth quarter. California Public Employees Retirement System now owns 106,400 shares of the company’s stock valued at $5,315,000 after buying an additional 11,100 shares in the last quarter. Finally, First Trust Advisors LP raised its stake in Exponent by 74.9% in the fourth quarter. First Trust Advisors LP now owns 26,087 shares of the company’s stock valued at $1,303,000 after buying an additional 11,171 shares in the last quarter.

Exponent, Inc, along with its subsidiaries, is a science and engineering consulting company. The Company operates through two segments: Engineering and Other Scientific, and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, engineering management consulting, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, technology development, thermal sciences and vehicle analysis services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.